0001144204-11-040566.txt : 20110714
0001144204-11-040566.hdr.sgml : 20110714
20110714155120
ACCESSION NUMBER: 0001144204-11-040566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110712
FILED AS OF DATE: 20110714
DATE AS OF CHANGE: 20110714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCCUBBIN JAMES T
CENTRAL INDEX KEY: 0001257635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 11968067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
BUSINESS PHONE: 2153450919
MAIL ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
v228704_ex.xml
X0303
4
2011-07-12
0
0000868278
ProPhase Labs, Inc.
PRPH
0001257635
MCCUBBIN JAMES T
621 N. SHADY RETREAT ROAD
DOYLESTOWN
PA
18901
1
0
0
0
Common Stock, par value $0.0005
2011-07-12
4
A
0
5460
0
A
19463
D
These restricted shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan for
Board fees payable to non-employee directors. The 2010 Directors' Equity Compensation Plan was approved by the Company's
stockholders on May 5, 2010.
/s/ James McCubbin
2011-07-14